Abilify and Weight decreased - a phase IV clinical study of FDA data
Summary:
Weight decreased is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cymbalta, and have Schizophrenia.
The phase IV clinical study analyzes which people have Weight decreased when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
What is Weight decreased?
Weight decreased is found to be associated with 3,395 drugs and 4,742 conditions by eHealthMe. Check the latest studies of Weight decreased.
97,308 people reported to have side effects when taking Abilify.
Among them, 1,743 people (1.79%) have Weight decreased.
Among these 1,743 people:
How long have people been on Abilify when they have Weight decreased? *
What is the gender of people who have Weight decreased when taking Abilify? *
What is the age of people who have Weight decreased when taking Abilify? *
What are other drugs people take besides Abilify? *
What are other side effects people have besides Weight decreased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and have Weight decreased?
- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,454 reports)
Weight decreased treatments and more:
- Weight decreased (364,522 reports)
How severe was Weight decreased and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
- Weight decreased and drugs with ingredients of aripiprazole (1,787 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weight decreased:
- Weight decreased (3,395 drugs)
Browse all the conditions that are associated with Weight decreased:
- Weight decreased (4,742 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Hydramine and Paroxetine Hydrochloride - now
- Could Nadolol cause Torsade De Pointes? - 2 seconds ago
- Could Atacand cause Aseptic Necrosis? - 3 seconds ago
- Drug interactions of Phenergan and Buspirone Hcl - 5 seconds ago
- Drug interactions of Klor-Con M20 and Spironolactone - 12 seconds ago
- Drug interactions of Levalbuterol Hydrochloride and Folic Acid - 14 seconds ago
- Could Palonosetron cause Death? - 22 seconds ago
- Valproate Sodium vs. Keppra Xr, side effect and effectiveness comparison - 24 seconds ago
- Could Ketotifen Fumarate cause Atrial Fibrillation/Flutter? - 31 seconds ago
- Could Mobic cause Procedural Pain? - 34 seconds ago